Mycosis fungoides laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Line 6: | Line 6: | ||
==Laboratory Tests== | ==Laboratory Tests== | ||
Laboratory tests for cutaneous T cell lymphoma include: | Laboratory tests for cutaneous T cell lymphoma include:<ref name="VuralAkay2018">{{cite journal|last1=Vural|first1=Seçil|last2=Akay|first2=Bengü Nisa|last3=Botsali|first3=Ayşenur|last4=Atilla|first4=Erden|last5=Parlak|first5=Nehir|last6=Okcu Heper|first6=Aylin|last7=Şanlı|first7=Hatice|title=Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis|journal=Turkish Journal of Hematology|volume=35|issue=1|year=2018|pages=35–41|issn=13007777|doi=10.4274/tjh.2016.0502}}</ref> | ||
* [[Complete blood count]] (CBC) | * [[Complete blood count]] (CBC) | ||
* Peripheral blood smear | * Peripheral blood smear |
Revision as of 15:55, 12 December 2018
Cutaneous T cell lymphoma Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Laboratory tests for cutaneous T cell lymphoma include complete blood count (CBC), blood chemistry studies, flow cytometry, immunohistochemistry, and immunophenotyping.
Laboratory Tests
Laboratory tests for cutaneous T cell lymphoma include:[1]
- Complete blood count (CBC)
- Peripheral blood smear
- Atypical T-cells (Sezary cells)
- Blood chemistry studies
- Flow cytometry
- Immunohistochemistry
- Immunophenotyping: Beta F1+, CD2-/+, CD3+, CD3- (CD4-positive variant), CD4+ (CD4-positive variant), CD4-, CD5-, CD7+/-, CD8+, CD8- (CD4-positive variant), Granzyme B+, and Perforin+
References
- ↑ Vural, Seçil; Akay, Bengü Nisa; Botsali, Ayşenur; Atilla, Erden; Parlak, Nehir; Okcu Heper, Aylin; Şanlı, Hatice (2018). "Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis". Turkish Journal of Hematology. 35 (1): 35–41. doi:10.4274/tjh.2016.0502. ISSN 1300-7777.